| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PTVE | Common Stock | Award | $0 | +3.06K | +1.89% | $0.00 | 165K | Dec 16, 2024 | Direct | F1 |
| transaction | PTVE | Common Stock | Award | $0 | +90.8K | +55.05% | $0.00 | 256K | Dec 16, 2024 | Direct | F2 |
| transaction | PTVE | Common Stock | Tax liability | -$1.03M | -59.3K | -23.17% | $17.32 | 197K | Dec 16, 2024 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents additional shares acquired by the reporting person in connection with the settlement of dividend equivalent rights upon the vesting of 39,890 restricted stock units that were otherwise scheduled to vest on March 2, 2025 but that were accelerated into 2024. |
| F2 | Represents shares acquired by the reporting person in connection with the vesting and settlement of 40,605 performance share units that were granted in 2022, together with associated dividend equivalent rights, that were otherwise scheduled to vest on March 2, 2025, but that were accelerated into 2024. Pursuant to the Agreement and Plan of Merger, dated as of December 9, 2024, by and among the Issuer, Novolex Holdings, LLC and Alpha Lion Sub, Inc., and the determination by the Compensation Committee of the Issuer's Board of Directors in relation to achievement of the performance criteria, the performance share units were settled at 200% of target. |
| F3 | The reported securities were withheld to satisfy the reporting person's tax liability in connection with the vesting of the aforementioned restricted stock units and performance share units. |